Skip to main content
大禹生物 logo

大禹生物 — Investor Relations & Filings

Ticker · 920970 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 384 across all filing types
Latest filing 2025-04-27 Audit Report / Informat…
Country CN China
Listing Beijing Stock Exchange 920970

About 大禹生物

http://www.sxdysw.cn/

Shanxi Dayu Biological Assistance Co., Ltd. specializes in the research, development, and production of advanced animal nutrition and health solutions. The company focuses on the manufacturing of feed additives, micro-ecological preparations, and biological feed products. Its core portfolio includes probiotics, enzyme preparations, and functional premixes designed to enhance livestock immunity, improve feed conversion rates, and promote sustainable farming practices. By leveraging biotechnology, the firm provides integrated solutions for the aquaculture and animal husbandry sectors, emphasizing scientific innovation and product quality to support the modernization of the agricultural supply chain.

Recent filings

Filing Released Lang Actions
2024年度会计师事务所履职情况评估报告
Audit Report / Information Classification · 95% confidence The document is titled '2024 年度会计师事务所履职情况评估报告' which translates to '2024 Annual Evaluation Report on the Performance of the Accounting Firm'. It details the evaluation of the audit firm 信永中和会计师事务所 for their audit work on the company's 2024 financial statements. The content includes information about the audit firm's background, their audit procedures, independence, and the company's assessment of their performance. It does not contain the actual audited financial statements or detailed financial data, but rather an evaluation of the audit firm's performance and compliance with auditing standards. This fits the definition of an Audit Report / Information (AR) as it is a standalone audit-related report focusing on audit firm performance and audit results, excluding the full annual report. The document length is 1839 characters, which is short but contains substantive audit evaluation content, not just an announcement or certification. Therefore, the correct classification is AR with high confidence. FY 2024
2025-04-27 Chinese
2024年度审计报告
Regulatory Filings
2025-04-27 Chinese
2024年度募集资金存放与使用情况的鉴证报告
Regulatory Filings
2025-04-27 Chinese
2024年度董事会审计委员会履职情况报告
Audit Report / Information Classification · 95% confidence The document is titled as the "2024年度董事会审计委员会履职情况报告" which translates to "2024 Annual Report on the Audit Committee's Performance." It details the audit committee's activities, meetings, supervision of external auditors, review of financial reports, and internal audit guidance during the 2024 fiscal year. The content focuses on the audit committee's duties and oversight rather than presenting full financial statements or a comprehensive annual report. It is a standalone report on audit committee activities and audit-related oversight, which fits the definition of an Audit Report / Information (AR). The document length is 2051 characters, which is relatively short but contains substantive content about audit committee work, not just an announcement or certification. Therefore, it is classified as AR with high confidence. FY 2024
2025-04-27 Chinese
董事会关于独立董事独立性自查情况的专项报告
Board/Management Information Classification · 95% confidence The document is a special report from the board of directors regarding the independence of the company's independent directors. It references compliance with regulatory rules about independent directors and assesses their independence based on various criteria. The document is a formal announcement about governance matters related to board members' independence, not a full annual report, audit report, or financial statement. It does not contain financial data or earnings information. This fits the category of Board/Management Information (MANG), which includes announcements about board matters and management information.
2025-04-27 Chinese
2024年度独立董事述职报告（吴秋生）
Board/Management Information Classification · 95% confidence The document is a detailed report by an independent director (吴秋生) of 山西大禹生物工程股份有限公司 for the year 2024. It covers the director's duties, attendance at board and shareholder meetings, communication with internal audit and external auditors, protection of minority shareholders, participation in training, and other related governance activities. The content focuses on the independent director's role and responsibilities rather than financial results or audit opinions. It is not an annual report, audit report, earnings release, or any other financial statement. Instead, it is a governance-related report specifically from an independent director about their duties and activities during the year. This fits best under Board/Management Information (MANG), which includes announcements or reports related to board members and senior management activities. The document length is under 5,000 characters but contains substantive content, not just an announcement of a report publication, so it is not RPA or RNS. Therefore, the classification is MANG with high confidence.
2025-04-27 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.